Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by Helsinki University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Helsinki University
ClinicalTrials.gov Identifier:
NCT00298337
First received: March 1, 2006
Last updated: October 17, 2006
Last verified: March 2006
  Purpose

The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants


Condition Intervention Phase
Atopic Dermatitis
Food Hypersensitivity
Allergic Rhinitis, Seasonal
Allergic Conjunctivitis
Asthma
Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by Helsinki University:

Study Start Date: October 1999
Estimated Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   37 Weeks to 42 Weeks
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • mother or father fo child with doctor diagnoses allergic disease

Exclusion Criteria:

  • prematurity, major malformations
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00298337

Locations
Finland
Helsinki University Central Hospital, Skin and Allergy Hospital
Helsinki, PO box 160, Finland, 00029 HUS
Sponsors and Collaborators
Helsinki University
Investigators
Study Chair: Erkki Savilahti, Professor Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland
  More Information

Additional Information:
No publications provided by Helsinki University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00298337     History of Changes
Other Study ID Numbers: T101060058;T1040A0002;T110612
Study First Received: March 1, 2006
Last Updated: October 17, 2006
Health Authority: Finland: Ethics Committee

Additional relevant MeSH terms:
Conjunctivitis
Conjunctivitis, Allergic
Dermatitis
Dermatitis, Atopic
Food Hypersensitivity
Hypersensitivity
Rhinitis, Allergic, Seasonal
Conjunctival Diseases
Eye Diseases
Genetic Diseases, Inborn
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Rhinitis
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic

ClinicalTrials.gov processed this record on November 20, 2014